Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low-Grade Serous Ovarian Cancer × Gynecologic × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 327 Uterine Cervical Neoplasms 207 Endometrial Neoplasms 203 Breast Neoplasms 98 Fallopian Tube Neoplasms 87 Colorectal Neoplasms 73 Carcinoma, Non-Small-Cell Lung 70 Neoplasms 65 Pancreatic Neoplasms 56 Stomach Neoplasms 48 Prostatic Neoplasms 48 Melanoma 47 Neoplasm Metastasis 46 Lung Neoplasms 43 Triple Negative Breast Neoplasms 42 Squamous Cell Carcinoma of Head and Neck 35 Urinary Bladder Neoplasms 34 Carcinoma, Ovarian Epithelial 32 Head and Neck Neoplasms 31 Esophageal Neoplasms 28 Carcinoma, Renal Cell 28 Vulvar Neoplasms 24 Sarcoma 23 Colonic Neoplasms 23 Carcinoma, Hepatocellular 22 Uterine Cervical Dysplasia 21 Uterine Neoplasms 20 Papillomavirus Infections 19 Small Cell Lung Carcinoma 18 Recurrence 17

Interventions

defactinib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06394804 2026-02-03

CHAMELEON

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Low-Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡